Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Soluble Human Epidermal Growth Factor Receptor 2 (sHER2) as a Potential Risk Assessment, Screening, and Diagnostic Biomarker of Lung Adenocarcinoma.

Cosentino-Boehm AL, Lafky JM, Greenwood TM, Kimbler KD, Buenafe MC, Wang Y, Branscum AJ, Yang P, Maihle NJ, Baron AT.

Diagnostics (Basel). 2013 Jan 14;3(1):13-32. doi: 10.3390/diagnostics3010013.

2.

Lung cancer risk test trial: study design, participant baseline characteristics, bronchoscopy safety, and establishment of a biospecimen repository.

Crawford EL, Levin A, Safi F, Lu M, Baugh A, Zhang X, Yeo J, Khuder SA, Boulos AM, Nana-Sinkam P, Massion PP, Arenberg DA, Midthun D, Mazzone PJ, Nathan SD, Wainz R, Silvestri G, Tita J, Willey JC.

BMC Pulm Med. 2016 Jan 22;16:16. doi: 10.1186/s12890-016-0178-4.

3.

LAP TGF-Beta Subset of CD4(+)CD25(+)CD127(-) Treg Cells is Increased and Overexpresses LAP TGF-Beta in Lung Adenocarcinoma Patients.

Islas-Vazquez L, Prado-Garcia H, Aguilar-Cazares D, Meneses-Flores M, Galicia-Velasco M, Romero-Garcia S, Camacho-Mendoza C, Lopez-Gonzalez JS.

Biomed Res Int. 2015;2015:430943. doi: 10.1155/2015/430943. Epub 2015 Oct 25.

4.

China national lung cancer screening guideline with low-dose computed tomography (2015 version).

Zhou QH, Fan YG, Bu H, Wang Y, Wu N, Huang YC, Wang G, Wang XY, Qiao YL.

Thorac Cancer. 2015 Nov;6(6):812-8. doi: 10.1111/1759-7714.12287. Epub 2015 Aug 4.

5.

An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice.

Wiener RS, Gould MK, Arenberg DA, Au DH, Fennig K, Lamb CR, Mazzone PJ, Midthun DE, Napoli M, Ost DE, Powell CA, Rivera MP, Slatore CG, Tanner NT, Vachani A, Wisnivesky JP, Yoon SH; ATS/ACCP Committee on Low-Dose CT Lung Cancer Screening in Clinical Practice.

Am J Respir Crit Care Med. 2015 Oct 1;192(7):881-91. doi: 10.1164/rccm.201508-1671ST.

PMID:
26426785
6.

Lung Cancer Risk Prediction Using Common SNPs Located in GWAS-Identified Susceptibility Regions.

Weissfeld JL, Lin Y, Lin HM, Kurland BF, Wilson DO, Fuhrman CR, Pennathur A, Romkes M, Nukui T, Yuan JM, Siegfried JM, Diergaarde B.

J Thorac Oncol. 2015 Nov;10(11):1538-45. doi: 10.1097/JTO.0000000000000666.

PMID:
26352532
7.

Should Never-Smokers at Increased Risk for Lung Cancer Be Screened?

ten Haaf K, de Koning HJ.

J Thorac Oncol. 2015 Sep;10(9):1285-91. doi: 10.1097/JTO.0000000000000593.

PMID:
26287320
8.

Clinical and Immunological Factors in Emphysema Progression. Five-Year Prospective Longitudinal Exacerbation Study of Chronic Obstructive Pulmonary Disease (LES-COPD).

Bhavani S, Tsai CL, Perusich S, Hesselbacher S, Coxson H, Pandit L, Corry DB, Kheradmand F.

Am J Respir Crit Care Med. 2015 Nov 15;192(10):1171-8. doi: 10.1164/rccm.201504-0736OC.

PMID:
26241705
9.

Current Smoking Dose-Dependently Associated with Decreased β-Cell Function in Chinese Men without Diabetes.

Wang C, Wang Y, Wu J, Liu S, Zhu Y, Lv S, Lin P, Wang X, Xu Y, Yu S, Chen G, Xiang Q.

J Diabetes Res. 2015;2015:841768. doi: 10.1155/2015/841768. Epub 2015 Jul 5.

10.

Screening for lung cancer using low-dose computed tomography: concerns about the application in low-risk individuals.

Cui JW, Li W, Han FJ, Liu YD.

Transl Lung Cancer Res. 2015 Jun;4(3):275-86. doi: 10.3978/j.issn.2218-6751.2015.02.05. Review.

11.

Association of the FAM46A gene VNTRs and BAG6 rs3117582 SNP with non small cell lung cancer (NSCLC) in Croatian and Norwegian populations.

Etokebe GE, Zienolddiny S, Kupanovac Z, Enersen M, Balen S, Flego V, Bulat-Kardum L, Radojčić-Badovinac A, Skaug V, Bakke P, Haugen A, Dembic Z.

PLoS One. 2015 Apr 17;10(4):e0122651. doi: 10.1371/journal.pone.0122651. eCollection 2015.

12.

A simple model for predicting lung cancer occurrence in a lung cancer screening program: The Pittsburgh Predictor.

Wilson DO, Weissfeld J.

Lung Cancer. 2015 Jul;89(1):31-7. doi: 10.1016/j.lungcan.2015.03.021. Epub 2015 Mar 28.

PMID:
25863905
13.

JNCI and cancer prevention.

Dunn BK, Ghosh S, Kramer BS.

J Natl Cancer Inst. 2015 Feb 24;107(3). pii: djv021. doi: 10.1093/jnci/djv021. Print 2015 Mar.

14.

Clinical characteristics and prognosis of incidentally detected lung cancers.

Quadrelli S, Lyons G, Colt H, Chimondeguy D, Buero A.

Int J Surg Oncol. 2015;2015:287604. doi: 10.1155/2015/287604. Epub 2015 Feb 3.

15.

Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement.

Mazzone P, Powell CA, Arenberg D, Bach P, Detterbeck F, Gould MK, Jaklitsch MT, Jett J, Naidich D, Vachani A, Wiener RS, Silvestri G.

Chest. 2015 Feb;147(2):295-303. doi: 10.1378/chest.14-2500.

16.

The ability of bilirubin in identifying smokers with higher risk of lung cancer: a large cohort study in conjunction with global metabolomic profiling.

Wen CP, Zhang F, Liang D, Wen C, Gu J, Skinner H, Chow WH, Ye Y, Pu X, Hildebrandt MA, Huang M, Chen CH, Hsiung CA, Tsai MK, Tsao CK, Lippman SM, Wu X.

Clin Cancer Res. 2015 Jan 1;21(1):193-200. doi: 10.1158/1078-0432.CCR-14-0748. Epub 2014 Oct 21.

17.

A review of cancer risk prediction models with genetic variants.

Wang X, Oldani MJ, Zhao X, Huang X, Qian D.

Cancer Inform. 2014 Sep 21;13(Suppl 2):19-28. doi: 10.4137/CIN.S13788. eCollection 2014. Review.

18.

The cytokinesis-blocked micronucleus assay as a strong predictor of lung cancer: extension of a lung cancer risk prediction model.

El-Zein RA, Lopez MS, D'Amelio AM Jr, Liu M, Munden RF, Christiani D, Su L, Tejera-Alveraz P, Zhai R, Spitz MR, Etzel CJ.

Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2462-70. doi: 10.1158/1055-9965.EPI-14-0462. Epub 2014 Aug 29.

19.

A risk prediction model for smoking experimentation in Mexican American youth.

Talluri R, Wilkinson AV, Spitz MR, Shete S.

Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2165-74. doi: 10.1158/1055-9965.EPI-14-0467. Epub 2014 Jul 25.

20.

Updates and controversies in the rapidly evolving field of lung cancer screening, early detection, and chemoprevention.

Kathuria H, Gesthalter Y, Spira A, Brody JS, Steiling K.

Cancers (Basel). 2014 May 16;6(2):1157-79. doi: 10.3390/cancers6021157.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk